BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4490 related articles for article (PubMed ID: 28444736)

  • 1. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor modulators for endometriosis.
    Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
    Sangkomkamhang US; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone for uterine fibroids.
    Tristan M; Orozco LJ; Steed A; Ramírez-Morera A; Stone P
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007687. PubMed ID: 22895965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-back therapy with GnRH analogues for uterine fibroids.
    Moroni RM; Martins WP; Ferriani RA; Vieira CS; Nastri CO; Candido Dos Reis FJ; Brito LG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010854. PubMed ID: 25793972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
    Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
    Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin for endometrial hyperplasia.
    Clement NS; Oliver TR; Shiwani H; Sanner JR; Mulvaney CA; Atiomo W
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012214. PubMed ID: 29077194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids.
    Bhave Chittawar P; Franik S; Pouwer AW; Farquhar C
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004638. PubMed ID: 25331441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of ulipristal acetate for symptomatic uterine fibroids.
    Ghonim M; Magdy R; Sabbour M; Ghonim M; Nabhan A
    Int J Gynaecol Obstet; 2019 Aug; 146(2):141-148. PubMed ID: 31127621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term and long-term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; Wilkinson J; Basevi V; Marata AM; Magrini N; D'Amico R; Bassi C; Maestri E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008536. PubMed ID: 27733017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to reduce haemorrhage during myomectomy for fibroids.
    Kongnyuy EJ; Wiysonge CS
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD005355. PubMed ID: 25125317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitors for uterine fibroids.
    Song H; Lu D; Navaratnam K; Shi G
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal preparations for uterine fibroids.
    Liu JP; Yang H; Xia Y; Cardini F
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial resection and ablation techniques for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Grigore M; Brown J; Hickey M; Farquhar C
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD001501. PubMed ID: 30667064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 225.